Catalytic asymmetric Nozaki-Hiyama propargylation with ligand 1c proceeds with good to excellent enantioselectivity. Tuning of ligand 1 dramatically changes the enantioselectivity, and we propose models A and B to explain the change and outcome of the enantioselectivity. 相似文献
A simple and rapid method for the determination of zinc pyrithione (ZPT) in antidandruff preparations by high-performance liquid chromatography (HPLC) has been developed. ZPT in samples was converted into a stable copper(II) complex by mixing with cupric sulphate solution followed by extraction with chloroform. HPLC was carried out on a Nucleosil 5 C18 column (15 cm X 4.6 mm I.D.) using methanol-water (3:2) as the mobile phase with UV detection at 320 nm. The calibration graph was linear from 0.1-0.5 micrograms for ZPT. The recoveries from four shampoos were 98.0-100.6% with high accuracy. 相似文献
Amyloidosis is a term referring to a group of various protein-misfolding diseases wherein normally soluble proteins form aggregates as insoluble amyloid fibrils. How, or whether, amyloid fibrils contribute to tissue damage in amyloidosis has been the topic of debate. In vitro studies have demonstrated the appearance of small globular oligomeric species during the incubation of amyloid beta peptide (Aβ). Nerve biopsy specimens from patients with systemic amyloidosis have suggested that globular structures similar to Aβ oligomers were generated from amorphous electron-dense materials and later developed into mature amyloid fibrils. Schwann cells adjacent to amyloid fibrils become atrophic and degenerative, suggesting that the direct tissue damage induced by amyloid fibrils plays an important role in systemic amyloidosis. In contrast, there is increasing evidence that oligomers, rather than amyloid fibrils, are responsible for cell death in neurodegenerative diseases, particularly Alzheimer’s disease. Disease-modifying therapies based on the pathophysiology of amyloidosis have now become available. Aducanumab, a human monoclonal antibody against the aggregated form of Aβ, was recently approved for Alzheimer’s disease, and other monoclonal antibodies, including gantenerumab, solanezumab, and lecanemab, could also be up for approval. As many other agents for amyloidosis will be developed in the future, studies to develop sensitive clinical scales for identifying improvement and markers that can act as surrogates for clinical scales should be conducted. 相似文献
Cellulose, the main component of plant cell walls, is degradable in nature. However, to the best of our knowledge, this is the first report that compares the biodegradability of cellulose fibers with different structures in natural waters. River water, brackish water, and seawater were collected from the Kamo River and Osaka Bay, Japan. Biodegradation of cellulose fibers with different structures and crystallinities, ramie, mercerized ramie, and regenerated cellulose fibers in the collected natural water was investigated in the dark at 20 °C for 30 days. The primary and aerobic ultimate biodegradability were evaluated by weight loss and biochemical oxygen demand (BOD) tests, respectively. In the weight-loss test, cellulose fibers were found to be degraded by more than 50% in any natural water within 30 days. However, in the BOD test, biodegradation was diminished, with values of 40%, 20–30%, and 2–10% in river water, brackish water, and seawater, respectively. These results indicate that cellulose fibers are easily degraded into fine fragments, but it is difficult to cause their ultimate decomposition into water and carbon dioxide. Existence of such a tendency in the degree of biodegradation among the cellulose fibers remains unclear. The molecular weight of cellulose fibers in natural water was also measured during their degradation. The degradation behavior in river water and seawater was observed to be different from that in brackish water. The results thus obtained indicate that the microorganisms and enzymes that degrade cellulose fibers differ depending on the natural water, which influences the degree and mechanism of biodegradation.